Choongwae; new anti-colon cancer drug under development.

Published: 2005-07-25 06:56:00

Updated: 2005-07-25 06:56:00

Choongwae and Japanese Chugai, an affiliate company of Roche, agreed on July 20 jointly to develope an innovative anti-cancer drug that had been studied since 2001 by Choongwae, initially for the treatment of colon cancer. Choongwae already developed the most optimized new candidate compound out ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK